
Carlsmed Inc (CARL) Stock Forecast & Price Target
Carlsmed Inc (CARL) Analyst Ratings
Bulls say
Carlsmed is a promising company in the medical technology industry, with its AI-enabled personalized platform positioned to revolutionize spine surgery. Key factors driving this positive outlook include strong third-party reimbursement, efficient production and delivery processes, and the company's expansion into the cervical spine market. Despite risks such as competition and reimbursement changes, Carlsmed's high growth and attractive hospital economics make it a compelling investment opportunity.
Bears say
Carlsmed is a single-segment, commercial-stage medical technology company focused on developing AI-enabled personalized solutions for spine surgery. Despite recent revenue upside and increased utilization, the company still faces potential challenges in expanding its customer base and gaining greater uptake of its Aprevo technology platform. Additionally, while the company has shown success in lumbar fusion, they may face more difficulties in launching and penetrating the cervical spine market due to a higher success rate of traditional fusion procedures and potential challenges in securing reimbursement and specific codes for custom implants.
This aggregate rating is based on analysts' research of Carlsmed Inc and is not a guaranteed prediction by Public.com or investment advice.
Carlsmed Inc (CARL) Analyst Forecast & Price Prediction
Start investing in Carlsmed Inc (CARL)
Order type
Buy in
Order amount
Est. shares
0 shares